Drug Trial Radar · NCT02837692
A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults
Last checked: Nov 20, 2026Latest source record: Oct 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Jun 8, 2016
Primary completion
Sep 7, 2017
Study completion Sep 11, 2017
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Jul 19, 2016
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the pharmacokinetics of single-dose evening administration of JNJ-42847922 in elderly non-Asian adults compared with weight- and gender-matched young healthy non-Asian adults and to assess the pharmacokinetics of single-dose evening administration of JNJ-42847922 in healthy Japanese adults.
Conditions
- Healthy
Interventions
JNJ-42847922 10 milligram (mg)Drug
JNJ-42847922 will be administered as single tablet of 10 mg, orally, once on Day 1.
JNJ-42847922 20 mgDrug
JNJ-42847922 will be administered as 1 tablet of 20 mg, orally, once on Day 1.
JNJ-42847922 40 mgDrug
JNJ-42847922 will be administered as 2 tablets of 20 mg, orally, once on Day 1.
JNJ-42847922 60 or 80 mgDrug
JNJ-42847922 will be administered as 3 or 4 tablets of 20 mg, orally, once on Day 1. Dose to be determined from Cohort 3, Period 1.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Plasma Concentration (Cmax) of JNJ-42847922Time frame: Day 1 (Pre-dose) up to Day 3
- Area Under the Plasma Concentration-Time Curve From Time Zero to Infinite Time (AUC [0-last]) of JNJ-42847922Time frame: Day 1 (Pre-dose) up to Day 3
- Area Under the Plasma Concentration-Time Curve From Time Zero to Infinite Time (AUC [0-infinity]) of JNJ-42847922Time frame: Day 1 (Pre-dose) up to Day 3
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Cypress, California
Site not named
Knoxville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.